First study of safety and tolerability of 3,4-methylenedioxymethamphetamine-assisted psychotherapy in patients with alcohol use disorder

Alcohol use and misuse during the COVID-19 pandemic: a potential public health crisis?

(2020) James M Clay et al.   Lancet Public Health

MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials

(2019) Michael C. Mithoefer et al.   PSYCHOPHARMACOLOGY

A Review of 3,4-methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy

(2019) Ben Sessa et al.   Frontiers in Psychiatry

Why MDMA therapy for alcohol use disorder? And why now?

(2017) Ben Sessa   NEUROPHARMACOLOGY

The Effects of Acutely Administered 3,4-Methylenedioxymethamphetamine on Spontaneous Brain Function in Healthy Volunteers Measured with Arterial Spin Labeling and Blood Oxygen Level–Dependent Resting State Functional Connectivity

(2015) Robin L. Carhart-Harris et al.   BIOLOGICAL PSYCHIATRY

Can psychedelic compounds play a part in drug dependence therapy?

(2015) Ben Sessa et al.   BRITISH JOURNAL OF PSYCHIATRY

The effect of acutely administered MDMA on subjective and BOLD-fMRI responses to favourite and worst autobiographical memories

(2013) R. L. Carhart-Harris et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study

(2012) Michael C Mithoefer et al.   JOURNAL OF PSYCHOPHARMACOLOGY

BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP

(2012) AR Lingford-Hughes et al.   JOURNAL OF PSYCHOPHARMACOLOGY

The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study

(2010) Michael C Mithoefer et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Last Observation Carried Forward Versus Mixed Models in the Analysis of Psychiatric Clinical Trials

(2009) Robert M. Hamer et al.   AMERICAN JOURNAL OF PSYCHIATRY

Brain serotonin transporter binding in former users of MDMA (‘ecstasy’)

(2009) Sudhakar Selvaraj et al.   BRITISH JOURNAL OF PSYCHIATRY

Neurocognitive impairments in MDMA and other drug users: MDMA alone may not be a cognitive risk factor

(2009) Karen L. Hanson et al.   JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY

Mindfulness-Based Therapies for Substance Use Disorders: Part 1

(2009) Marianne T. Marcus et al.   Substance Abuse